Completed
Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
NCT00123760
- Conditions
- Brain Diseases, Brain Neoplasms, Central Nervous System Diseases, +31 more
- Locations
-
- Cross Cancer Institute Edmonton, Alberta, Canada